Suggestions
Jane Buchan
CEO at PAAMCO
Jane Buchan is a prominent figure in the asset management industry with a distinguished career spanning academia, entrepreneurship, and leadership roles. Here's an overview of her professional journey:
Career Highlights
Jane Buchan is currently the Chief Executive Officer of Martlet Asset Management, LLC, based in Newport Beach, California.12 Prior to her current role, she co-founded Pacific Alternative Asset Management Company (PAAMCO) in 2000, which grew to become a significant player in the hedge fund industry.1
PAAMCO Leadership: Under Buchan's leadership, PAAMCO expanded significantly:
- The firm merged with Prisma Capital Partners, LP in June 2017, forming PAAMCO Prisma Holdings, LLC.1
- As of June 30, 2018, PAAMCO Prisma had $32 billion in assets under management (AUM).12
- It became the third-largest fund of funds firm globally, according to HFM InvestHedge Billion Dollar Club: H1 2018.1
Academic Background: Buchan's career also includes notable academic achievements:
- She served as an Assistant Professor of Finance at the Amos Tuck School of Business at Dartmouth.1
- She holds MA and PhD degrees from Harvard University.1
Professional Recognition
Buchan has received numerous accolades throughout her career:
- Named to the Barron's 100 Most Influential Women in US Finance in 2020 and 2021.1
- Received the "2014 North American Industry Leadership Award" from 100 Women in Hedge Funds.1
- Named one of "50 Women in Hedge Funds" by The Hedge Fund Journal and Ernst & Young multiple times.1
- Inducted into the InvestHedge Hall of Fame in 2015.1
Industry Involvement
Buchan is actively involved in various professional associations:
- Served as Director and Chair of the Board for the Chartered Alternative Investment Analyst Association (CAIA).1
- Associate Editor for the Journal of Alternative Investments.1
- Trustee of the Standard Boards for Alternative Investments.1
Board Positions
She holds several board positions:
- Director for AGF Management (TSE
.B).1 - Director for IMMIX Biopharma (NASDAQ: IMMX).1
- Former director of Globe Life (NYSE
) from 2005 to 2024.1
Jane Buchan's career demonstrates a unique blend of academic expertise, entrepreneurial success, and industry leadership in the asset management sector.